World Health Organisation data reveal that Malawi has made notable strides in combating tuberculosis, with a significant decline in incidence and deaths over the past decade. The country's estimated TB incidence rate has decreased to 107 per 100,000 people, down from 198 in 2015. This represents a 46% reduction in TB incidence since 2015, bringing Malawi close to the 50% milestone set under the global End TB Strategy for 2025.
Deaths caused by TB have also declined substantially, with an estimated 4,100 people dying from TB in 2025, down from around 12,100 deaths in 2015. This marks a 66% reduction in TB deaths since 2015, approaching the ambitious 75% milestone for 2025 and moving Malawi toward the 90% target for 2030. The WHO report attributes Malawi's progress to steady gains in prevention, diagnosis, and treatment.
Progress has also been registered against drug-resistant TB, with the proportion of Rifampicin-Resistant TB among new cases falling from 2.1% in 2015 to below 1% by 2025. Among previously treated cases, RR-TB declined from 6% in 2015 to around 5% in 2025. The estimated number of people who developed RR-TB decreased from 1,000 in 2015 to 400 in 2025, easing pressure on specialised treatment centres and drug supplies.
Despite these gains, men aged 25 to 44 still carry the highest TB burden in 2025. Health officials stress that targeted screening, HIV testing, and community outreach must continue to sustain progress nationwide. International Coalition on Health Financing Advocacy chairperson Maziko Matemba notes that TB in Malawi has historically been driven by HIV co-infection, and scaling up antiretroviral therapy and integrated HIV-TB screening has been crucial in cutting mortality rates.
Matemba urges the government to prioritise domestic treasury allocations for essential TB drugs and diagnostic cartridges, citing financing challenges. Meanwhile, WHO Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections director Tereza Kasaeva says Malawi's achievement demonstrates what is possible when commitment is translated into action.
Kasaeva emphasises that the WHO is working with countries to build on this momentum, expanding access to rapid diagnosis and effective treatment, and bringing new tools and innovations to those in need. Globally, the TB incidence rate was 129 new cases per 100,000 populations in 2025, a 1.6% decline compared with 131 in 2024 and a 14% decrease from 2015.
The WHO report also notes a reduction in total funding and USG bilateral funding between 2024 and 2025, which may impact progress. However, Malawi's achievement serves as a testament to the effectiveness of concerted efforts in combating TB, and the country is expected to continue its progress in the fight against the disease.
Key points
- Malawi cuts TB incidence by 46% and deaths by 66% over 10 years
- Progress registered against drug-resistant TB, with RR-TB declining among new and previously treated cases
- Men aged 25 to 44 still carry the highest TB burden in 2025, requiring targeted screening and outreach efforts
Reporting sources
- WHO data show Malawi made progress in TB fight · The Nation